Multi-omic analysis identifies hypoalbuminemia as independent biomarker of poor outcome upon PD-1 blockade in metastatic melanoma

  • Lindsay V.M. Leek
  • , Jessica C.L. Notohardjo
  • , Karlijn de Joode
  • , Eline L. Velker
  • , John B.A.G. Haanen
  • , Karijn P.M. Suijkerbuijk
  • , Maureen J.B. Aarts
  • , Jan Willem B. de Groot
  • , Ellen Kapiteijn
  • , Franchette W.P.J. van den Berkmortel
  • , Hans M. Westgeest
  • , Tanja D. de Gruijl
  • , Valesca P. Retel
  • , Edwin Cuppen
  • , Astrid A.M. van der Veldt
  • , Mariette Labots
  • , Emile E. Voest
  • , Joris van de Haar*
  • , Alfons J.M. van den Eertwegh*
  • *Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

7 Citations (Scopus)
32 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Multi-omic analysis identifies hypoalbuminemia as independent biomarker of poor outcome upon PD-1 blockade in metastatic melanoma'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology